Kriya Therapeutics
PrivateLast Round
Series D
Sep 10, 2025
Total Funding Raised
$1.08B
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kriya Therapeutics is a biotechnology company that designs and develops gene therapies for chronic diseases affecting large patient populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kriya Therapeutics Comparables
Compare Kriya Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ring Therapeutics | 82% | |
| 4DMT | 81% | |
| Frontera Therapeutics | 81% | |
Kriya Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2025 | ||||
| Series C Extension | Jul 26, 2023 | ||||
| Series C | May 16, 2022 | ||||
| Series B | Jul 14, 2021 | ||||
| Series A | May 12, 2020 | ||||
Seed | Oct 1, 2019 |
Key People
Founding team and executive leadership
Kriya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Narya Capital | Series C, Series B, Series A, Series D |
| CAM Capital | Series C, Series B |
| Amplo | Series B, Series A |
| Patient Square Capital | Series C, Series C Extension, Series B, Series D |
| Hongkou Capital | Series B |
| Foresite Capital | Series C, Series B, Series A |
| PBM Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2026
Hiring business owner for Dot Compliance eQMS platform.
- Sep 10, 2025
$320M Series D round completed.
Kriya Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kriya Therapeutics's valuation, stock price, and market status.